CardiologyOnline.net

Cardiology Xagena

Search results for "Digoxin"

Digoxin significantly reduces the likelihood of hospital admission due to all causes among ambulatory older patients with chronic heart failure and reduced ejection fraction ( HFrEF ), according to re ...


A study published in the European Heart Journal found no evidence that Digoxin increases mortality in patients with atrial fibrillation ( AF ), the opposite of results just published by another group ...


Digoxin, a drug that has been used worldwide for centuries to treat heart disease, is associated with a significant increase in deaths in patients with atrial fibrillation ( AF ), according to results ...


Digoxin, a drug commonly used to treat heart conditions, was associated with a 72% higher rate of death among adults with newly diagnosed systolic heart failure, according to a study that appears in t ...


Despite endorsement of Digoxin in clinical practice guidelines, there exist limited data on its safety in atrial fibrillation / atrial flutter. The goal of a study was to evaluate the association o ...


Dronedarone ( Multaq ) is a non-iodinated benzofuran derivative with antiarrhythmic properties. In placebo-controlled atrial fibrillation ( AF ) trials, the drug was found to have divergent effects on ...


The American Association for Thoracic Surgery ( AATS ) has released new evidence-based guidelines for the prevention and treatment of perioperative and postoperative atrial fibrillation ( POAF ) and f ...


Digoxin remains commonly used for rate control in atrial fibrillation, but very limited data exist supporting this practice and some studies have shown an association with adverse outcomes. Research ...


Symptoms are a major driver for patients with atrial fibrillation to seek medical attention and are important to titrate atrial fibrillation therapies. However, a large proportion of patients with atr ...


Edoxaban ( Lixiana ), an oral direct factor Xa inhibitor, is in development for thromboprophylaxis, including prevention of stroke and systemic embolism in patients with atrial fibrillation. P-glyco ...


Dronedarone ( Multaq ) is a non-iodinated benzofuran derivative with antiarrhythmic properties. In placebo-controlled atrial fibrillation trials, the drug was found to have divergent effects on endpoi ...


Elevated serum Digoxin concentration can cause toxicity, including death. Dronedarone ( Multaq ) increases Digoxin concentration by P-glycoprotein interaction. In PALLAS ( Permanent Atrial Fibrillat ...


Patients taking Digoxin ( Lanoxin ) to control atrial fibrillation face a 27% greater risk of dying than atrial fibrillation patients who are not taking digoxin, according to an analysis of 19 studies ...


The 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension are published in the European Heart Journal and the European Respiratory Journal. The document was written joint ...


Amid growing uncertainty about the safety of Digoxin, a commonly used heart drug, a study led by Duke Clinical Research Institute found that people with atrial fibrillation should avoid taking the dru ...